Medical News

RSS

Æterna Zentaris receives notification letter over non-compliance with NASDAQ Listing Rule

Æterna Zentaris Inc. (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, today announced that on January 21, 2010, the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market indicating that the minimum closing bid price of its common shares had fallen below US$1.00 for 30 consecutive trading days, and therefore, Æterna Zentaris was not in compliance with NASDAQ Listing Rule 5450(a)(1) (the "Rule").

22 Jan 2010

Health Policy Research: Covering young adults, Acos, wellness programs

Dependent Coverage Expansions: Estimating the Impact of Current State Policies - "With an estimated 29.3 percent of Americans age 19 to 29 lacking coverage, young adults are more likely to be uninsured than any other age group," the authors note.

22 Jan 2010

Access Pharmaceuticals to sell 2.10M shares in registered direct offering

ACCESS PHARMACEUTICALS, INC., today announced that it has entered into definitive agreements with accredited investors to sell in a registered direct offering an aggregate of 2.10 million shares of its common stock at a price of $3.00 per share for aggregate gross proceeds of $6.3 million.

22 Jan 2010

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

GenVec, Inc. announced today that data from the Company's trial in esophageal cancer were presented at the American Society of Clinical Oncology's 2010 Gastrointestinal Cancer Symposium in Orlando, Florida on January 22, 2010.

22 Jan 2010

A selection of today's opinions and editorials

We will ultimately have real health care reform in this country for a very simple reason: We have no choice and both Democrats and Republicans understand that. More importantly, the American people know it (Robert Laszewski, 1/22).

22 Jan 2010

Democrats struggle to revamp health reform strategy

Efforts to save the reform effort were teetering "on the brink of collapse Thursday as House and Senate leaders struggled to coalesce around a strategy to rescue the plan," Politico reports.

22 Jan 2010

Curis prices registered direct offering

Curis, Inc. announced today that it has priced a registered direct offering of 6,449,288 units, at a price of $2.52 per unit, for gross proceeds of $16.25 million before deducting placement agents’ fees and estimated offering expenses. Each unit consists of one share of the company's common stock and a warrant to buy 0.25 of a share of the company's common stock. The warrants will be exercisable for a period of five years beginning on the date of issuance, at an exercise price of $3.55 per share.

22 Jan 2010

NIH awards grants to develop new tobacco-related drug therapies

Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.

22 Jan 2010

Progress in Anadys Pharmaceuticals' Phase II study of ANA598 announced

Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.

22 Jan 2010

APX Alarm and IASK team up to support Haiti relief efforts

APX Alarm, one of the nation’s largest home security companies, today announced that it has partnered with International Aid Serving Kids (IASK) to help support the Haiti earthquake relief efforts.

22 Jan 2010

California revives bill to create single-payer health care system

The Associated Press/Los Angeles Times: "A key legislative committee in California revived a bill Thursday to create a government-run health care system in the nation's most populous state ... The legislation had been held over from last year because of the state's ongoing budget crisis. The full Senate could vote on the bill by next week. Creating a single-payer system would cost California an estimated $210 billion in its first year. That's roughly double the size of the total state budget..." (Thompson, 1/21).

22 Jan 2010

Aid flow to Haiti improves as seaport opens, airport volume dramtically increases

Nine days after a major earthquake struck, "deeply needed aid streamed into Haiti's ravaged capital in quantities that relief agencies said is a clear sign of progress," the Miami Herald reports.

22 Jan 2010

BioSyent Pharma receives exclusive rights to manufacture and market Virsani sanitizer in Canada and U.S.

BioSyent Inc. ("BioSyent") announces that its subsidiary BioSyent Pharma Inc. has signed a license and distribution agreement with Notlers for VirsaniTM personal sanitizer.

22 Jan 2010

Acorda Therapeutics receives marketing approval from FDA for AMPYRA

Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS).

22 Jan 2010

Tips to make healthy lifestyle changes

As January comes to a close, will your New Year's resolution end with it? If you find yourself struggling to keep your resolution, you're not alone, says William Manard, M.D., Saint Louis University assistant professor of family and community medicine.

22 Jan 2010

Researchers produce DVD to help patients live with and manage neuropathic pain

Health professionals and patients can now go online for help and tips from a groundbreaking pain clinic, which halved referrals to hospital.

22 Jan 2010

AHF/Magic Johnson ‘Testing America’ tour to conduct testing event at Albuquerque, New Mexico

AHF’s Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, will tumble into Albuquerque, New Mexico for a testing event at El Mezquite Market from 10am to 2pm Friday January 22nd. Free testing will take place on AHF’s new, state-of-the-art ‘Testing America’ mobile HIV testing unit. AHF is working in conjunction with New Mexico AIDS Services, a respected local non-profit HIV/AIDS organization.

22 Jan 2010

Findings offer potential significance to the recovery of walking after spinal cord injury

Researchers at the medical university Karolinska Institutet have created a genetically modified mouse in which certain neurons can be activated by blue light. Shining blue light on brainstems or spinal cords isolated from these mice produces walking-like motor activity. The findings, which are published in the scientific journal Nature Neuroscience, are of potential significance to the recovery of walking after spinal cord injury.

22 Jan 2010

First Edition: January 22, 2010

Today's news highlights the continued efforts by Democrats to plot a new health reform strategy.

22 Jan 2010

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Genetic diseases like those seen in the new Harrison Ford movie "Extraordinary Measures" can now be prevented with a simple saliva test which is free with insurance for more than 100 million Americans.

22 Jan 2010

Medical News

Æterna Zentaris receives notification letter over non-compliance with NASDAQ Listing Rule

Health Policy Research: Covering young adults, Acos, wellness programs

Access Pharmaceuticals to sell 2.10M shares in registered direct offering

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

A selection of today's opinions and editorials

Democrats struggle to revamp health reform strategy

Curis prices registered direct offering

NIH awards grants to develop new tobacco-related drug therapies

Progress in Anadys Pharmaceuticals' Phase II study of ANA598 announced

APX Alarm and IASK team up to support Haiti relief efforts

California revives bill to create single-payer health care system

Aid flow to Haiti improves as seaport opens, airport volume dramtically increases

BioSyent Pharma receives exclusive rights to manufacture and market Virsani sanitizer in Canada and U.S.

Acorda Therapeutics receives marketing approval from FDA for AMPYRA

Tips to make healthy lifestyle changes

Researchers produce DVD to help patients live with and manage neuropathic pain

AHF/Magic Johnson ‘Testing America’ tour to conduct testing event at Albuquerque, New Mexico

Findings offer potential significance to the recovery of walking after spinal cord injury

First Edition: January 22, 2010

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News